why choose us

First received: October 31, 2022

Clinical Trial: Inhaled Nitric Oxide for Microvascular Dysfunction in Traumatic Brain Injury

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Traumatic Brain Injury

Study Type: INTERVENTIONAL


Official Title: Inhaled Nitric Oxide for Microvascular Dysfunction in Traumatic Brain Injury

Brief Summary: Traumatic brain injury (TBI) causes acute deficits in cerebral perfusion which may lead to secondary injury and worse outcomes.Inhaled nitric oxide (iNO) is a vasodilator that increases cerebral blood flow and is clinically used for hypoxic respiratory failure in neonates and adults.The investigators will perform a randomized controlled trial of iNO treatment in TBI patients acutely after injury.The investigators will then assess perfusion changes with optic neuromonitoring, blood biomarkers, and 6 month clinical…

Read more